Active Filter(s):
Details:
The funding will be used to build our laboratory site in Graz, Austria, and further fuel three in-house drug programs around neurology and oncology. This means a substantial acceleration on a global scale of the platform.
Lead Product(s): Undisclosed
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Small molecule
Partner/Sponsor/Collaborator: Pace Ventures Enigma
Deal Size: $4.4 million Upfront Cash: Undisclosed
Deal Type: Financing February 10, 2022